153 related articles for article (PubMed ID: 7630151)
21. Effects of U-97018 on pressor responses to intracerebroventricularly administered angiotensin II in conscious normotensive rats.
Morita O; Kushida H; Kunihara M
J Cardiovasc Pharmacol; 1995 Jun; 25(6):880-7. PubMed ID: 7564332
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of angiotensin II-induced facilitation of sympathetic neurotransmission in the pithed rat: a comparison between losartan, irbesartan, telmisartan, and captopril.
Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
J Hypertens; 2001 Mar; 19(3):465-73. PubMed ID: 11288817
[TBL] [Abstract][Full Text] [Related]
23. Enhancement of losartan (DuP 753)-induced angiotensin II receptor antagonism by PD123177 in rats.
Wong PC; Christ DD; Timmermans PB
Eur J Pharmacol; 1992 Sep; 220(2-3):267-70. PubMed ID: 1425998
[TBL] [Abstract][Full Text] [Related]
24. BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174.
Dickinson KE; Cohen RB; Skwish S; Delaney CL; Serafino RP; Poss MA; Gu Z; Ryono DE; Moreland S; Powell JR
Br J Pharmacol; 1994 Sep; 113(1):179-89. PubMed ID: 7812609
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of sympathetic outflow by the angiotensin II receptor antagonist, eprosartan, but not by losartan, valsartan or irbesartan: relationship to differences in prejunctional angiotensin II receptor blockade.
Ohlstein EH; Brooks DP; Feuerstein GZ; Ruffolo RR
Pharmacology; 1997 Nov; 55(5):244-51. PubMed ID: 9399334
[TBL] [Abstract][Full Text] [Related]
26. A non-competitive type of angiotensin-receptor antagonism by losartan in renal artery preparations.
Zhang J; Pfaffendorf M; Zhang JS; Van Zwieten PA
Eur J Pharmacol; 1994 Feb; 252(3):337-40. PubMed ID: 8162955
[TBL] [Abstract][Full Text] [Related]
27. Effects of the AT1 antagonist HR 720 in comparison to losartan on stimulated sympathetic outflow, blood pressure, and heart rate in pithed spontaneously hypertensive rats.
Häuser W; Dendorfer A; Nguyen T; Dominiak P
Kidney Blood Press Res; 1998; 21(1):29-35. PubMed ID: 9661134
[TBL] [Abstract][Full Text] [Related]
28. In vivo pharmacological characterization of UP 269-6, a novel nonpeptide angiotensin II receptor antagonist.
Cazes M; Provost D; Versigny A; Cloarec A
Eur J Pharmacol; 1995 Sep; 284(1-2):157-70. PubMed ID: 8549620
[TBL] [Abstract][Full Text] [Related]
29. In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.
Siegl PK; Chang RS; Mantlo NB; Chakravarty PK; Ondeyka DL; Greenlee WJ; Patchett AA; Sweet CS; Lotti VJ
J Pharmacol Exp Ther; 1992 Jul; 262(1):139-44. PubMed ID: 1625193
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological characteristics of the positive inotropic effect of angiotensin II in the rabbit ventricular myocardium.
Ishihata A; Endoh M
Br J Pharmacol; 1993 Apr; 108(4):999-1005. PubMed ID: 8387388
[TBL] [Abstract][Full Text] [Related]
31. Nonpeptide angiotensin II receptor antagonists. Studies with DuP 753 and EXP3174 in dogs.
Wong PC; Hart SD; Duncia JV; Timmermans PB
Eur J Pharmacol; 1991 Sep; 202(3):323-30. PubMed ID: 1748155
[TBL] [Abstract][Full Text] [Related]
32. AT1 receptors mediate the release of prostaglandins in porcine smooth muscle cells and rat astrocytes.
Leung KH; Chang RS; Lotti VJ; Roscoe WA; Smith RD; Timmermans PB; Chiu AT
Am J Hypertens; 1992 Sep; 5(9):648-56. PubMed ID: 1418854
[TBL] [Abstract][Full Text] [Related]
33. Different types of receptor interaction of peptide and nonpeptide angiotensin II antagonists revealed by receptor binding and functional studies.
Wienen W; Mauz AB; Van Meel JC; Entzeroth M
Mol Pharmacol; 1992 Jun; 41(6):1081-8. PubMed ID: 1614410
[TBL] [Abstract][Full Text] [Related]
34. Angiotensin II receptor type I-regulated anion secretion in cystic fibrosis pancreatic duct cells.
Chan HC; Law SH; Leung PS; Fu LX; Wong PY
J Membr Biol; 1997 Apr; 156(3):241-9. PubMed ID: 9096065
[TBL] [Abstract][Full Text] [Related]
35. Modulation of net outward current in cultured neurons by angiotensin II: involvement of AT1 and AT2 receptors.
Kang J; Sumners C; Posner P
Brain Res; 1992 May; 580(1-2):317-24. PubMed ID: 1504808
[TBL] [Abstract][Full Text] [Related]
36. The in vitro pharmacological profile of KR31080, a nonpeptide AT1 receptor antagonist.
Hong KW; Kim CD; Lee SH; Yoo SE
Fundam Clin Pharmacol; 1998; 12(1):64-9. PubMed ID: 9523186
[TBL] [Abstract][Full Text] [Related]
37. Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of benzimidazoles.
Kubo K; Inada Y; Kohara Y; Sugiura Y; Ojima M; Itoh K; Furukawa Y; Nishikawa K; Naka T
J Med Chem; 1993 Jun; 36(12):1772-84. PubMed ID: 8510105
[TBL] [Abstract][Full Text] [Related]
38. Modulation of tachyphylaxis to angiotensin II in rabbit isolated aorta by the angiotensin AT1 receptor antagonist, losartan.
Robertson MJ; Wragg A; Clark KL
Regul Pept; 1994 Feb; 50(2):137-45. PubMed ID: 8190915
[TBL] [Abstract][Full Text] [Related]
39. Effects of irbesartan (SR47436/BMS-186295) on angiotensin II-induced pressor responses in the pithed rat: potential mechanisms of action.
Christophe B; Libon R; Cazaubon C; Nisato D; Manning A; Chatelain P
Eur J Pharmacol; 1995 Aug; 281(2):161-71. PubMed ID: 7589203
[TBL] [Abstract][Full Text] [Related]
40. In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation.
Virone-Oddos A; Desangle V; Provost D; Cazes M; Caussade F; Cloarec A
Br J Pharmacol; 1997 Feb; 120(3):488-94. PubMed ID: 9031754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
